Importantly, the upregulation of PIWIL2, which encodes a key factor in the piRNA pathway, independently predicted poor prognosis in MDS patients, underscoring its potential as a valuable disease marker. This evidence concerns the gene PIWIL2 and myelodysplastic syndrome.